Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xeomin add-on to Sildenafil for ED
NCT05196308Phase 2Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2022
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in erectile dysfunction (ED), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
erectile dysfunction (ED)
Beyond the preview
Go deeper on NCT05196308.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05196308.